Product Program year 2019 Source: CMS Open Payments

Oncology TA

Drug Oncology

Open in the dashboard

General payments

$146,783

45 payments

Research payments

$0

0 payments

Through program year 2019, $146,783 in general payments and $0 in research payments were reported against Oncology TA (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $146,783 45

Breakdown

Who paid General payments · program year 2019
  1. Hikma Pharmaceuticals USA $146,783 45 payments
Top recipients General payments · program year 2019
  1. Elias Jabbour Hematology & Oncology · Houston, TX $19,029 13% · 5 payments
  2. Nuhad Ibrahim Medical Oncology · Houston, TX $18,978 13% · 4 payments
  3. Hagop Kantarjian Medical Oncology · Houston, TX $17,809 12% · 5 payments
  4. Susan O Brien Medical Oncology · Orange, CA $15,182 10% · 5 payments
  5. Farhad Ravandi-Kashani Hematology & Oncology · Houston, TX $15,085 10% · 5 payments

The top 5 of 10 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $67,871 46% · 5 practitioners
  2. Medical Oncology Internal Medicine $65,395 45% · 4 practitioners
  3. Internal Medicine $13,517 9% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. Texas $138,653 94% · 9 recipients
  2. New York $8,130 6% · 1 recipient

Each share is of general payments naming this product in 2019 where a state was reported.

45 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record